tiprankstipranks

Stuart Arbuckle Insider Profile

4 Followers
Stuart Arbuckle, EVP & COO at Vertex Pharmaceuticals, holds 49.83K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 0.00 shares in ImmunoGen (Ticker: IMGN), holds ― shares in Rhythm Pharmaceuticals (Ticker: RYTM).
tipranks
Stuart Arbuckle

Stuart Arbuckle
Vertex Pharmaceuticals (VRTX)
EVP & COO

Ranked #20,767 out of 98,501 Corporate Insiders

Profitable Transactions

88%
7 out of 8 Profitable Transactions

Average Return

+7.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20M
100.00%
0.00%
0.00%
A breakdown of Stuart Arbuckle's holdings

Insider Roles

Vertex Pharmaceuticals
(VRTX)
EVP & COO
Rhythm Pharmaceuticals
(RYTM)
Director
Daré Bioscience
(DARE)
Director
Roles that Stuart Arbuckle holds in companies

Most Profitable Insider Trade

Stock:
Vertex Pharmaceuticals
(VRTX)
Rating:Informative Buy
Date:Nov 05, 2018 - Nov 05, 2019
Return:+12.90%
The most profitable trade made by Stuart Arbuckle

Stuart Arbuckle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vertex Pharmaceuticals
Feb 27, 2024
EVP & COO
Uninformative Sell
2.14M
$19.76M
IMGN
ImmunoGen
Feb 12, 2024
Uninformative Sell
$0.00
Rhythm Pharmaceuticals
Director
Daré Bioscience
Jan 05, 2017
Director
Uninformative Buy
5.75K
$0.00
List of latest transactions for each holding click on a transaction to see Stuart Arbuckle's performance on stock

Stuart Arbuckle insider profile FAQ

What is the percentage of profitable transactions made by Stuart Arbuckle?
The percentage of profitable transactions made by Stuart Arbuckle is 88%.
    What is the average return per transaction made by Stuart Arbuckle?
    The average return per transaction made by Stuart Arbuckle is 7.50%.
      What stocks does Stuart Arbuckle hold?
      Stuart Arbuckle holds: VRTX, IMGN, RYTM, DARE stocks.
        What was Stuart Arbuckle’s latest transaction?
        Stuart Arbuckle latest transaction was an Uninformative Sell of $2.14M.
          What was Stuart Arbuckle's most profitable transaction?
          Stuart Arbuckle’s most profitable transaction was an Informative Buy of VRTX stock on November 5, 2018. The return on the trade was 12.90%.
            What is Stuart Arbuckle's role in Vertex Pharmaceuticals?
            Stuart Arbuckle's role in Vertex Pharmaceuticals is EVP & COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.